Back to 
DODGE & COX
DODGE & COXGSGSK1
Showing 0 of 16 quarters
Position history for DODGE & COX's holdings in GLAXOSMITHKLINE PLC-SPON ADR
As of its Q2 2022 13F, Dodge & Cox held 74,242,722 shares of GSK1 (Glaxosmithkline), worth $3.2B. Dodge & Cox's 13F filings listed GSK1 from Q4 2018 to Q2 2022, 15 quarterly filings. GSK1 was 2.2% of Dodge & Cox's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.